BIOMAT Database Logo BIOMAT Database Logo

Overview on bioavailability and bioequivalence. 1976

S A Kaplan

UI MeSH Term Description Entries
D011619 Psychotropic Drugs A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). Psychoactive Agent,Psychoactive Agents,Psychoactive Drug,Psychopharmaceutical,Psychopharmaceuticals,Psychotropic Drug,Psychoactive Drugs,Agent, Psychoactive,Agents, Psychoactive,Drug, Psychoactive,Drug, Psychotropic,Drugs, Psychoactive,Drugs, Psychotropic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013810 Therapeutic Equivalency The relative equivalency in the efficacy of different modes of treatment of a disease, most often used to compare the efficacy of different pharmaceuticals to treat a given disease. Bioequivalence,Clinical Equivalency,Equivalency, Therapeutic,Generic Equivalency,Clinical Equivalencies,Equivalencies, Clinical,Equivalencies, Therapeutic,Equivalency, Clinical,Therapeutic Equivalencies,Bioequivalences,Equivalencies, Generic,Equivalency, Generic,Generic Equivalencies

Related Publications

S A Kaplan
Bioavailability and bioequivalence: an FDA regulatory overview.
December 2001, Pharmaceutical research,
S A Kaplan
Bioavailability and bioequivalence.
October 1976, Journal of clinical pharmacology,
S A Kaplan
Japanese guidance on bioavailability and bioequivalence.
January 2000, European journal of drug metabolism and pharmacokinetics,
S A Kaplan
Society testifies on bioavailability, bioequivalence.
September 1975, Pennsylvania medicine,
S A Kaplan
Editorial: Bioavailability, bioequivalence and bias.
March 1975, American journal of ophthalmology,
S A Kaplan
Generic drugs: bioequivalence and bioavailability.
January 1988, JAMA,
S A Kaplan
[Generic drugs, bioavailability, and bioequivalence].
January 1998, Gaceta medica de Mexico,
S A Kaplan
Bioequivalence/bioavailability retention samples.
January 1993, Quality assurance (San Diego, Calif.),
S A Kaplan
Bioavailability and bioequivalence: focus on physiological factors and variability.
August 2008, Pharmaceutical research,
S A Kaplan
Bioavailability and Bioequivalence in Drug Development.
January 2014, Wiley interdisciplinary reviews. Computational statistics,
Copied contents to your clipboard!